Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Regulus Therapeutics Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +1 vs. Q3 2023
- Shares held
- 11.1M
- +211.9K (+1.9%) vs. Q3 2023
- Total value
- $14.2M
- −$783.1K (−5.2%) vs. Q3 2023
- New holders
- 3
- 6 more added
- Sold out
- 2
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $760 |
| Q1 2025 | 75 | $107.0M |
| Q4 2024 | 69 | $84.5M |
| Q3 2024 | 70 | $89.1M |
| Q2 2024 | 63 | $109.5M |
| Q1 2024 | 45 | $147.3M |
| Q4 2023 | 26 | $14.2M |
| Q3 2023 | 25 | $15.0M |
| Q2 2023 | 26 | $15.0M |
| Q1 2023 | 27 | $6.82M |
| Q4 2022 | 28 | $11.1M |
| Q3 2022 | 25 | $13.8M |
| Q2 2022 | 28 | $12.6M |
| Q1 2022 | 37 | $18.1M |
| Q4 2021 | 38 | $9.54M |
| Q3 2021 | 42 | $15.9M |
| Q2 2021 | 45 | $18.7M |
| Q1 2021 | 44 | $42.6M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Regulus Therapeutics Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 466 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 80 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 11 | $14 | 0.00% | +11 | New |
| Tower Research Capital LLC (TRC) | 17 | $22 | 0.00% | −3,569−99.5% | Reduced |
| JPMorgan Chase & Co | 29 | $37 | 0.00% | +9+45.0% | Added |
| Wells Fargo & Company | 140 | $180 | 0.00% | +12+9.4% | Added |
| UBS Group AG | 344 | $440 | 0.00% | −64−15.7% | Reduced |
| BlackRock Inc. | 573 | $733 | 0.00% | −45−7.3% | Reduced |
| Community Bank, N.A. | 690 | $876 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,123 | $2.72K | 0.00% | +2,123 | New |
| Grimes & Company, Inc. | 10,420 | $13.3K | 0.00% | −127−1.2% | Reduced |
| Commonwealth Equity Services, LLC | 17,500 | $22.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,978 | $23.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 28,461 | $36.4K | 0.00% | +16,746+142.9% | Added |
| Prelude Capital Management, LLC | 40,260 | $51.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 41,719 | $53.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 54,600 | $70.0K | 0.00% | +4,500+9.0% | Added |
| Geode Capital Management, LLC | 122,521 | $156.9K | 0.00% | 00.0% | Unchanged |
| Exome Asset Management LLC | 178,404 | $228.4K | 0.23% | +178,404 | New |
| Sarissa Capital Management LP | 185,183 | $237.0K | 0.04% | 00.0% | Unchanged |
| Victory Capital Management Inc | 271,736 | $347.8K | 0.00% | +38,529+16.5% | Added |
| Vanguard Group Inc | 286,431 | $366.6K | 0.00% | +1,381+0.5% | Added |
| DAFNA Capital Management LLC | 1,111,049 | $1.42M | 0.34% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,945,579 | $2.49M | 0.17% | 00.0% | Unchanged |
| FMR LLC | 2,922,600 | $3.74M | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,875,578 | $4.96M | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,921−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |